Evolving Strategies for Leveraging SGLT2 Inhibitor Therapy in Type 2 Diabetes

Download All
Get patient-specific guidance on T2D treatment options and insights on managing CVD and CKD risk.
Anne Peters, MD

Interactive Virtual Presentation

Hear expert discussion of the role of SGLT-2 inhibitors in treating type 2 diabetes.

Anne Peters, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Released: December 10, 2020 Expired: December 9, 2021
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by an independent educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue